0
Articles   |    
Adult-Onset Mitochondrial Myopathy Coexistent with Lumbar Disc Disease. A Case Report*
ROBERT E. CASHMAN, M.D.†; G. DAVID CASPER, M.D.‡; ROGER A. BRUMBACK, M.D.†, OKLAHOMA CITY, OKLAHOMA
View Disclosures and Other Information
Investigation performed at the Department of Pathology, University of Oklahoma Health Sciences Center, and Laboratory Service, Veterans Affairs Medical Center, and Southwest Medical Center, Oklahoma City
The Journal of Bone & Joint Surgery.  1996; 78:767-71 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case
Mitochondrial diseases are a heterogeneous group of disorders. Abnormal mitochondria may be seen to have altered histological characteristics with the use of light microscopy or at the ultrastructural level, abnormal DNA sequences, alterations in the levels and function of enzymes, or a combination of these abnormalities12,17.
In mitochondrial myopathies, symptoms often are limited to muscle; patients usually have slowly progressive weakness and, frequently, ophthalmoplegia. Weakness generally begins between birth and the age of ten months and is transiently exacerbated by exercise16. The weakness usually is in the proximal portion of the limb but can be in the distal area11. Occasionally, weakness does not appear until adulthood1,2,5,8-10,13,18,19,23.
We report on a patient who had lumbar disc disease and previously undiagnosed mitochondrial myopathy, resulting in long-standing weakness of the muscles of the lower extremities and radicular pain. A decompressive procedure was done for a bulging disc at the fifth lumbar-first sacral interspace, and the radicular pain resolved but the weakness persisted. Additional evaluation, including muscle biopsy, revealed the characteristic features of mitochondrial myopathy. We believe that the coexistence of lumbar disc disease and mitochondrial myopathy in our patient was a unique finding.

*No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.

†Department of Pathology, University of Oklahoma Health Sciences Center, BMSB-451,940 Stanton L. Young Boulevard, Oklahoma City, Oklahoma 73104.

‡Southwest Medical Center, 1016 S.W. 44th Street, Suite 500, Oklahoma City, Oklahoma 73109.

*No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.
†Department of Pathology, University of Oklahoma Health Sciences Center, BMSB-451,940 Stanton L. Young Boulevard, Oklahoma City, Oklahoma 73104.
‡Southwest Medical Center, 1016 S.W. 44th Street, Suite 500, Oklahoma City, Oklahoma 73109.
 
Anchor for JumpAnchor for Jump
+Figs. 1-A through 1-D: The muscle biopsy showed evidence of mitochondrial myopathy. Figs. 1-A and 1-B: Light microscopy with trichrome stain (Fig. 1-A) and succinate dehydrogenase stain (Fig. 1-B) showed ragged-red fibers (arrows) (x 400).
 
Anchor for JumpAnchor for Jump
+Figs. 1-A and 1-B: Light microscopy with trichrome stain (Fig. 1-A) and succinate dehydrogenase stain (Fig. 1-B) showed ragged-red fibers (arrows) (x 400).
 
Anchor for JumpAnchor for Jump
+Figs. 1-C and 1-D: Electron microscopy showed the abnormal arrangement of cristae in enlarged mitochondria (arrows).
 
Anchor for JumpAnchor for Jump
+Figs. 1-C and 1-D: Electron microscopy showed the abnormal arrangement of cristae in enlarged mitochondria (arrows).
A seventy-six-year-old man had had intermittent low-back pain for approximately fifty years, which he related to the lifting of very heavy objects. He was evaluated five years after the first episode for low-back pain that radiated into the right lower extremity; he had weakness of both lower extremities and paresthesia in the right lower extremity. The diagnosis was a compression fracture of the fifth lumbar vertebra, and the patient was managed with analgesics, vitamins, and testosterone.
Although the symptoms persisted intermittently, the patient had no medical evaluation until myelography and computed tomography were done (not at our institution) when he was seventy-four years old. These studies revealed diffuse bulging of the disc at the fifth lumbar-first sacral interspace, with impingement on both first sacral nerve roots, but this was not definitively treated. Two years later, the patient was seen by one of us (G.D.C.) because of low-back pain that radiated into both lower extremities. The pain was more severe on the right than on the left, and there was numbness and weakness in the right lower extremity. Physical examination revealed sensory loss in the second lumbar to first sacral dermatomes involving all modalities in both lower extremities, which was worse on the right; weakness of both lower extremities, which was most pronounced proximally in the iliopsoas and quadriceps but was also present in the muscles in the anterior and posterior compartments of the thighs; absence of all reflexes in the lower extremities; positive straight-leg-raising tests at 30 degrees on the right and at 45 degrees on the left; and no abnormal findings in the upper extremities.
Magnetic resonance imaging of the lumbar spine confirmed a diffuse bulging of the disc at the fifth lumbar-first sacral interspace, which impinged on the nerve roots bilaterally in the neural foramina. Percutaneous laser-assisted decompression of the disc was done.
Postoperatively, the patient had relief of pain but continued to have weakness in both lower extremities, most pronounced in the quadriceps, and he had intolerance to exercise. Additionally, he continued to have sensory loss involving all modalities in a stocking distribution in both lower extremities and normal sensation in both upper extremities. The stocking distribution suggested a non-radicular neurogenic etiology for the sensory loss. Electromyography revealed a decreased number of motor units as well as decreased insertional activity in the intrinsic muscles of the foot; evidence of acute denervation in muscles innervated by the fifth lumbar root, including the tibialis anterior, peronei, and tibialis posterior muscles; and increased insertional activity with occasional positive waves in the quadriceps and gluteus medius. The findings in the upper extremities were normal.
The patient had two open biopsies of the right quadriceps muscle, which revealed changes consistent with mitochondrial myopathy (Figs. 1-A and 1-B), including ragged-red fibers with clumped staining by reduced nicotinamide-adenine dinucleotide, succinate dehydrogenase, and cytochrome oxidase. The variation in the size of fibers was increased, and occasional dark angulated fibers, consistent with denervation, stained positively for esterase. Electron microscopy revealed collections of enlarged and abnormally shaped mitochondria that contained cristae with abnormal morphology, dense osmiophilic inclusions, and lipid droplets (Figs. 1-C and 1-D). Biochemical analysis revealed a deficiency of multiple enzymes, suggestive of a large deletion of mitochondrial DNA. The muscle mitochondria had decreased activity of cytochrome-c oxidase (0.23 micromole per minute per gram; normal, 2.28 to 3.32 micromoles per minute per gram), succinate cytochrome-c reductase (0.20 micromole per minute per gram; normal, 0.47 to 0.93 micromole per minute per gram), rotenone-sensitive nicotinamide-adenine dinucleotide cytochrome-c reductase (0.54 micromole per minute per gram; normal, 0.64 to 1.40 micromoles per minute per gram), reduced nicotinamide-adenine dinucleotide dehydrogenase (8.30 micromoles per minute per gram; normal, 28.41 to 42.55 micromoles per minute per gram), and citrate synthase (1.53 micromoles per minute per gram; normal, 7.33 to 12.53 micromoles per minute per gram). Succinate dehydrogenase activity was normal (1.53 micromoles per minute per gram; normal, 0.47 to 1.53 micromoles per minute per gram). After the biopsy, the resting level of serum lactate was elevated (3.0 millimoles per liter; normal, less than 2.2 millimoles per liter); this was additional evidence that mitochondrial myopathy was the cause of the weakness. Subsequently, empirical therapy was started with a daily regimen of forty milligrams of vitamin K3 (menadione), four grams of vitamin C (ascorbate), ten milligrams of coenzyme Q (ubiquinone), and one megavitamin. This treatment resulted in subjective improvement—the patient said that he was able to be more active—but not in objective improvement. One year later, the patient died of cardiac disease, and permission for an autopsy was not obtained.
Most patients who have mitochondrial myopathy become symptomatic between birth and the age of ten months16, but there have been a few reports of adult-onset disease. The cases of five patients who had maternally inherited myopathy and cardiomyopathy with onset between the ages of nineteen and thirty years were reported23. Two patients were initially seen because of intolerance to exercise when they were forty-three and forty-six years old. The first patient was seen four months after therapy with valproate had been initiated for epilepsy2,13. Other patients were seen because of weakness. One patient, fifty-nine years old, sought medical attention because he had had weakness of the lower extremities with pain for ten years9. This patient and another patient had myopathy characterized histologically by polyglycosan inclusions surrounded by mitochondria with abnormal structure. Three other patients were sixty-seven to eighty years old when they were first seen with proximal myopathy as the only feature8, and proximal weakness developed in a sixty-six-year-old patient after five years of therapy with clofibrate1. Two patients were fifty-six and seventy years old when they were first seen with respiratory failure as the predominant manifestation of weakness5. Other patients who have had adult onset of the disease have included a forty-eight-year-old woman who had a nine-year history of cerebellar ataxia, weakness, and mental confusion, followed by myoclonus11, and an eighty-year-old patient who had a long history of hearing loss and episodes of abnormal movements of the limbs accompanied by ataxia and confusion19. There were also reports of a forty-six-year-old patient who had mononeuritis multiplex18 and a fifty-five-year-old patient who had ptosis, ophthalmoplegia, and dysphagia10. Thus, mitochondrial myopathy can present in adulthood with a variety of symptoms.
Our patient had a symptomatic herniated nucleus pulposus coexisting with mitochondrial myopathy. After decompression of the fifth lumbar-first sacral disc space, the patient had considerable relief of the radicular pain, indicating that the herniated nucleus pulposus was indeed responsible for this symptom. However, the proximal weakness of the lower extremities and the intolerance to exercise persisted postoperatively. Although the weakness in mitochondrial myopathy occasionally occurs distally, it more commonly occurs proximally11. The weakness is often variable, and its course may be stable or progressive6. Typically, it worsens transiently with exercise16. In addition, any physiological perturbations, such as extreme elevation of ambient temperature, physical exertion, hypoglycemia, stress, and infection, may exacerbate the symptoms14.
In patients who have mitochondrial myopathy, a pure myopathy often is demonstrated, whereas symptoms related to the central nervous system dominate the clinical symptomatology in myoencephalopathies4. Several syndromes in this latter category have been described, including myoclonic epilepsy with ragged-red fibers21, Kearns-Sayre syndrome21, and the syndrome of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes6. Patients who have myoclonic epilepsy with ragged-red fibers have intention myoclonus, epilepsy, ataxia, muscular weakness, deafness, and dementia21. Patients who have the syndrome of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes are normal at birth but fail to thrive, with episodic vomiting, seizures, and recurrent cerebral insults developing in the first year of life6. Patients who have Kearns-Sayre syndrome have short stature, chronic progressive external ophthalmoplegia, cerebellar ataxia, pigmentary retinopathy, an increased level of protein in the cerebrospinal fluid, heart block, dementia, hearing loss, and muscular weakness21.
Although myopathic findings are the most common electromyographic abnormalities in patients who have mitochondrial myopathy6,7, neurogenic changes, as found in our patient, may also be seen. In one study of mitochondrial myopathy20, clinical evidence of sensorimotor neuropathy was identified in five of twenty patients, whereas abnormal nerve-conduction velocity was seen in ten. In that series, nerve biopsies from several patients revealed decreased numbers of myelinated fibers, evidence of axonal degeneration, and characteristic mitochondrial paracrystalline inclusions20. Our patient had decreased nerve-conduction velocity in the distribution of the right fifth lumbar nerve root but normal nerve-conduction velocities in the upper extremities. Thus, it is difficult to exclude the possibility that the aberrant nerve-conduction studies were secondary to radiculopathy and were not due to neurogenic changes secondary to mitochondrial myopathy.
The muscle biopsies in our patient revealed the characteristic features that are seen in mitochondrial myopathy, including ragged-red fibers and abnormal clumped staining by succinate dehydrogenase, reduced nicotinamide-adenine dinucleotide, and cytochrome oxidase22. Abnormal fibers are irregularly distributed through the muscle (as in our patient), often representing less than 25 per cent of all muscle fibers11, and the number of ragged-red fibers does not correspond to the severity of the disease16. The appearance of ragged-red fibers with the use of light microscopy results from the accumulation of abnormal mitochondria22, which can be seen with electron microscopy. As in our patient, the characteristic mitochondrial abnormalities include collections of enlarged and abnormally shaped mitochondria, abnormal cristae, lipid droplets, and osmiophilic inclusions6. Biochemical analysis of muscle specimens from our patient demonstrated deficiencies of multiple mitochondrial enzymes. In some patients, specific biochemical defects can be linked to the disease manifestions (such as deficiency of cytochrome-c oxidase in fatal infantile mitochondrial myopathy22). However, in most patients, as in ours, there are multiple biochemical defects. Furthermore, even with isolated defects, the symptomatology can vary. For example, in one series of eight patients who had defects involving only complex III (reduced coenzyme Q-cytochrome-c reductase) of the respiratory chain, five had pure myopathy, whereas the other three had encephalomyopathy6.
For our patient, empirical therapy consisted of a daily regimen of forty milligrams of vitamin K3 (menadione), four grams of vitamin C (ascorbate), ten milligrams of coenzyme Q (ubiquinone), and one therapeutic multivitamin. Przyrembel pointed out that therapy for defects of the respiratory chain is difficult because of the heterogeneity of symptoms and localization of the defect. In addition, the episodic nature of the clinical symptoms makes it difficult to assess the therapeutic benefit. Both vitamin K3 and vitamin C have redox potentials that allow them to substitute for complex III of the respiratory chain. Complex III of the electron transport chain consists of coenzyme Q-cytochrome-c reductase. Because the redox potentials of vitamin K3 and vitamin C are comparable with the potential of complex-III components, they can act as electron acceptors in lieu of deficient complex-III components and can effectively bypass the deficit. Vitamin K3 was reported to be successful in bypassing a defect of complex I in one patient15, and the combination of vitamin K3 and vitamin C was successful in a patient who had a deficiency of complex III15. Coenzyme Q, which serves as an electron carrier in the respiratory chain, was effective in both improving symptoms and normalizing serum levels of lactate in one patient who had Kearns-Sayre syndrome15. A variety of additional vitamins that are precursors of coenzymes have been utilized in an attempt to stimulate the activity and production of enzymes15. Patients who have mitochondrial myopathy should avoid certain medications because of their adverse effect on mitochondrial function. Valproate sequesters carnitine, barbiturates inhibit enzymes in the respiratory chain, and tetracycline and chloramphenicol inhibit mitochondrial protein synthesis15.
Our report illustrates the importance of considering mitochondrial myopathy in patients who have intervertebral disc disease but no clear-cut radiculopathy. Our patient's activity had been limited by pain from disc disease, but weakness and intolerance to exercise persisted postoperatively. A patient who has weakness that is exacerbated by exercise should be evaluated for the possibility of mitochondrial myopathy. Although the level of serum lactate was measured after the diagnosis of mitochondrial myopathy had been made pathologically, to ascertain the clinical-pathological association between the patient's weakness and mitochondrial myopathy, assessment of the resting level of serum lactate is a good non-invasive screening test to rule out mitochondrial myopathy. In our patient, the elevated level of lactate supported the pathological diagnosis of a mitochondrial disorder, although some patients may have a normal resting level of serum lactate that increases during minimum exercise14. An elevated level of serum lactate that cannot be explained by other means should be further evaluated by muscle biopsy in which light microscopic histochemical study3, electron microscopy, and biochemical analysis are performed. To preserve mitochondrial enzyme activity for the biochemical studies, part of the specimen must be frozen immediately in the operating room in liquid nitrogen or dry ice.
Bardosi, A.; Scheidt, P.; and |and |Goebel, H. H.: Mitochondrial myopathy—a result of clofibrate/etofibrate treatment? Case report. Acta Neuropathol.,68: 164-168, 1985.68164  1985  [PubMed][CrossRef]
 
Beyenburg, S.; von Wersebe, O.; and |and |Zierz, S.: Spätmanifestation einer mitochondrialen Myopathie-Komplex-I-und-IV-Mangel der mitochondrialen Atmungskette mit progredienten Paresen. Nervenarzt,62: 506-511, 1991.62506  1991  [PubMed]
 
Brumback, R. A., and Leech, R. W.: Color Atlas of Muscle Histochemistry. Littleton, Massachusetts, PSG Publishing, 1984. 
 
Byrne, E.: Mitochondrial myopathies and myoencephalopathies. Curr. Opin. Rheumatol.,2: 889-895, 1990.2889  1990  [PubMed][CrossRef]
 
Cros, D.; Palliyath, S.; DiMauro, S.; Ramirez, C.; Shamsnia, M.; and |and |Wizer, B.: Respiratory failure revealing mitochondrial myopathy in adults. Chest,101: 824-828, 1992.101824  1992  [PubMed][CrossRef]
 
DiMauro, S.; Bonilla, E.; Zeviani, M.; Nakagawa, M.; and |and |DeVivo, D.C.: Mitochondrial myopathies. Ann. Neurol.,17: 521-538, 1985.17521  1985  [PubMed][CrossRef]
 
Emeryk, B.; Rowin ska-Marcinska, K.; Nowak-Michalska, T.; and |and |Sawicka, E.: Muscular fatigability in mitochondrial myopathies. An electrophysiological study. Electromyog. and Clin. Neurophysiol.,32: 235-245, 1992.32235  1992 
 
Fernandez-Sola, J.; Casademont, J.; Grau, J. M.; Graus, F.; Cardellach, F.; Pedrol, E.; and |and |Urbano-Marquez, A.: Adult-onset mitochondrial myopathy. Postgrad. Med. J.,68: 212-215, 1992.68212  1992  [PubMed][CrossRef]
 
Goebel, H. H.; Shin, Y. S.; Gullotta, F.; Yokota, T.; Alroy, J.; Voit, T.; Haller, P.; and |and |Schulz, A.: Adult polyglycosan body myopathy. J. Neuropathol. and Exper. Neurol.,51: 24-35, 1992.5124  1992  [CrossRef]
 
Marcacci, G.; Siciliano, G.; Bevilacqua, G.; Viacava, P.; and |and |Rossi, B.: Miopatia oculo-faringea mitocondriale: descrizione di un caso. Riv. Neurol.,60: 198-200, 1990.60198  1990  [PubMed]
 
Mastaglia, F. L., and Walton, J.: Skeletal Muscle Pathology, pp. 309-339. New York, Churchill Livingstone, 1982. 
 
Morgan-Hughes, J. A., and Landon, D. N.: Mitochondrial Pathology in Muscle Disease, pp. 19-37. Padua, Italy, Privin Medical Books, 1983. 
 
Papadimitriou, A., and |and |Servidei, S.: Late onset lipid storage myopathy due to multiple acylCoA dehydrogenase deficiency triggered by valproate. Neuromusc. Disord.,1: 247-252, 1991.1247  1991  [PubMed][CrossRef]
 
Peterson, P. L.; Martens, M. E.; and |and |Lee, C. P.: Mitochondrial encephalomyopathies. Neurol. Clin.,6: 529-544, 1988.6529  1988  [PubMed]
 
Przyrembel, H.: Therapy of mitochondrial disorders. J. Inherit. Metabol. Dis.,10(Supplement 1): 129-146, 1987.10(Supplement 1)129  1987  [CrossRef]
 
Sengers, R. C.; Stadhouders, A.M.; and |and |Trijbels, J. M.: Mitochondrial myopathies. Clinical, morphological and biochemical aspects. European J. Pediat.,141: 192-207, 1984.141192  1984  [CrossRef]
 
Shanske, S.: Mitochondrial encephalomyopathies: defects of nuclear DNA. Brain Pathol.,2: 159-162, 1992.2159  1992  [PubMed][CrossRef]
 
Shiro, Y., and |and |Yabuki, S.: [A case of mitochondrial myopathy with mononeuritis multiplex]. Rinsho Shinkeigaku,30: 745-749, 1990.30745  1990  [PubMed]
 
Vaamonde, J.; Muruzabal, J.; Tunon, T.; Perez, N.; Artieda, J.; Rodriguez, M.; and |and |Obeso, J. A.: Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome). J. Neurol., Neurosurg., and Psychiat.,55: 128-132, 1992.55128  1992  [CrossRef]
 
Yiannikas, C.; McLeod, J. G.; Pollard, J. D.; and |and |Baverstock, J.: Peripheral neuropathy associated with mitochondrial myopathy. Ann. Neurol.,20: 249-257, 1986.20249  1986  [PubMed][CrossRef]
 
Zeviani, M., and |and |Antozzi, C.: Defects of mitochondrial DNA. Brain Pathol.,2: 121-132, 1992.2121  1992  [PubMed][CrossRef]
 
Zeviani, M.; Bonilla, E.; DeVivo, D.C.; and |and |DiMauro, S.: Mitochondrial diseases. Neurol. Clin.,7: 123-156, 1989.7123  1989  [PubMed]
 
Zeviani, M.; Gellera, C.; Antozzi, C.; Rimoldi, M.; Morandi, L.; Villani, F.; Tiranti, V.; and |and |DiDonato, S.: Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). Lancet,338: 143-147, 1991.338143  1991  [PubMed][CrossRef]
 

Submit a comment

Topics

Anchor for JumpAnchor for Jump
+Figs. 1-A through 1-D: The muscle biopsy showed evidence of mitochondrial myopathy. Figs. 1-A and 1-B: Light microscopy with trichrome stain (Fig. 1-A) and succinate dehydrogenase stain (Fig. 1-B) showed ragged-red fibers (arrows) (x 400).
Anchor for JumpAnchor for Jump
+Figs. 1-A and 1-B: Light microscopy with trichrome stain (Fig. 1-A) and succinate dehydrogenase stain (Fig. 1-B) showed ragged-red fibers (arrows) (x 400).
Anchor for JumpAnchor for Jump
+Figs. 1-C and 1-D: Electron microscopy showed the abnormal arrangement of cristae in enlarged mitochondria (arrows).
Anchor for JumpAnchor for Jump
+Figs. 1-C and 1-D: Electron microscopy showed the abnormal arrangement of cristae in enlarged mitochondria (arrows).
Bardosi, A.; Scheidt, P.; and |and |Goebel, H. H.: Mitochondrial myopathy—a result of clofibrate/etofibrate treatment? Case report. Acta Neuropathol.,68: 164-168, 1985.68164  1985  [PubMed][CrossRef]
 
Beyenburg, S.; von Wersebe, O.; and |and |Zierz, S.: Spätmanifestation einer mitochondrialen Myopathie-Komplex-I-und-IV-Mangel der mitochondrialen Atmungskette mit progredienten Paresen. Nervenarzt,62: 506-511, 1991.62506  1991  [PubMed]
 
Brumback, R. A., and Leech, R. W.: Color Atlas of Muscle Histochemistry. Littleton, Massachusetts, PSG Publishing, 1984. 
 
Byrne, E.: Mitochondrial myopathies and myoencephalopathies. Curr. Opin. Rheumatol.,2: 889-895, 1990.2889  1990  [PubMed][CrossRef]
 
Cros, D.; Palliyath, S.; DiMauro, S.; Ramirez, C.; Shamsnia, M.; and |and |Wizer, B.: Respiratory failure revealing mitochondrial myopathy in adults. Chest,101: 824-828, 1992.101824  1992  [PubMed][CrossRef]
 
DiMauro, S.; Bonilla, E.; Zeviani, M.; Nakagawa, M.; and |and |DeVivo, D.C.: Mitochondrial myopathies. Ann. Neurol.,17: 521-538, 1985.17521  1985  [PubMed][CrossRef]
 
Emeryk, B.; Rowin ska-Marcinska, K.; Nowak-Michalska, T.; and |and |Sawicka, E.: Muscular fatigability in mitochondrial myopathies. An electrophysiological study. Electromyog. and Clin. Neurophysiol.,32: 235-245, 1992.32235  1992 
 
Fernandez-Sola, J.; Casademont, J.; Grau, J. M.; Graus, F.; Cardellach, F.; Pedrol, E.; and |and |Urbano-Marquez, A.: Adult-onset mitochondrial myopathy. Postgrad. Med. J.,68: 212-215, 1992.68212  1992  [PubMed][CrossRef]
 
Goebel, H. H.; Shin, Y. S.; Gullotta, F.; Yokota, T.; Alroy, J.; Voit, T.; Haller, P.; and |and |Schulz, A.: Adult polyglycosan body myopathy. J. Neuropathol. and Exper. Neurol.,51: 24-35, 1992.5124  1992  [CrossRef]
 
Marcacci, G.; Siciliano, G.; Bevilacqua, G.; Viacava, P.; and |and |Rossi, B.: Miopatia oculo-faringea mitocondriale: descrizione di un caso. Riv. Neurol.,60: 198-200, 1990.60198  1990  [PubMed]
 
Mastaglia, F. L., and Walton, J.: Skeletal Muscle Pathology, pp. 309-339. New York, Churchill Livingstone, 1982. 
 
Morgan-Hughes, J. A., and Landon, D. N.: Mitochondrial Pathology in Muscle Disease, pp. 19-37. Padua, Italy, Privin Medical Books, 1983. 
 
Papadimitriou, A., and |and |Servidei, S.: Late onset lipid storage myopathy due to multiple acylCoA dehydrogenase deficiency triggered by valproate. Neuromusc. Disord.,1: 247-252, 1991.1247  1991  [PubMed][CrossRef]
 
Peterson, P. L.; Martens, M. E.; and |and |Lee, C. P.: Mitochondrial encephalomyopathies. Neurol. Clin.,6: 529-544, 1988.6529  1988  [PubMed]
 
Przyrembel, H.: Therapy of mitochondrial disorders. J. Inherit. Metabol. Dis.,10(Supplement 1): 129-146, 1987.10(Supplement 1)129  1987  [CrossRef]
 
Sengers, R. C.; Stadhouders, A.M.; and |and |Trijbels, J. M.: Mitochondrial myopathies. Clinical, morphological and biochemical aspects. European J. Pediat.,141: 192-207, 1984.141192  1984  [CrossRef]
 
Shanske, S.: Mitochondrial encephalomyopathies: defects of nuclear DNA. Brain Pathol.,2: 159-162, 1992.2159  1992  [PubMed][CrossRef]
 
Shiro, Y., and |and |Yabuki, S.: [A case of mitochondrial myopathy with mononeuritis multiplex]. Rinsho Shinkeigaku,30: 745-749, 1990.30745  1990  [PubMed]
 
Vaamonde, J.; Muruzabal, J.; Tunon, T.; Perez, N.; Artieda, J.; Rodriguez, M.; and |and |Obeso, J. A.: Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome). J. Neurol., Neurosurg., and Psychiat.,55: 128-132, 1992.55128  1992  [CrossRef]
 
Yiannikas, C.; McLeod, J. G.; Pollard, J. D.; and |and |Baverstock, J.: Peripheral neuropathy associated with mitochondrial myopathy. Ann. Neurol.,20: 249-257, 1986.20249  1986  [PubMed][CrossRef]
 
Zeviani, M., and |and |Antozzi, C.: Defects of mitochondrial DNA. Brain Pathol.,2: 121-132, 1992.2121  1992  [PubMed][CrossRef]
 
Zeviani, M.; Bonilla, E.; DeVivo, D.C.; and |and |DiMauro, S.: Mitochondrial diseases. Neurol. Clin.,7: 123-156, 1989.7123  1989  [PubMed]
 
Zeviani, M.; Gellera, C.; Antozzi, C.; Rimoldi, M.; Morandi, L.; Villani, F.; Tiranti, V.; and |and |DiDonato, S.: Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). Lancet,338: 143-147, 1991.338143  1991  [PubMed][CrossRef]
 
Accreditation Statement
These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
CME Activities Associated with This Article
Submit a Comment
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe




Related Articles
Related Cases
Related Content
Topic Collections
Related Audio and Videos
Clinical Trials
Readers of This Also Read...
jbjs jobs
12/22/2011
VA - Charleston Area Medical Center
12/22/2011
ME - Central Maine Medical Center
12/22/2011
Maine - Central Maine Medical Center